DE69715878T2 - Formulierung zur behandlung und/oder vorbeugung von dementia - Google Patents

Formulierung zur behandlung und/oder vorbeugung von dementia

Info

Publication number
DE69715878T2
DE69715878T2 DE69715878T DE69715878T DE69715878T2 DE 69715878 T2 DE69715878 T2 DE 69715878T2 DE 69715878 T DE69715878 T DE 69715878T DE 69715878 T DE69715878 T DE 69715878T DE 69715878 T2 DE69715878 T2 DE 69715878T2
Authority
DE
Germany
Prior art keywords
dementia
prevention
formula
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69715878T
Other languages
English (en)
Other versions
DE69715878D1 (de
Inventor
Schie Dirk M J Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE69715878D1 publication Critical patent/DE69715878D1/de
Application granted granted Critical
Publication of DE69715878T2 publication Critical patent/DE69715878T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69715878T 1996-07-25 1997-07-14 Formulierung zur behandlung und/oder vorbeugung von dementia Expired - Fee Related DE69715878T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9615628.6A GB9615628D0 (en) 1996-07-25 1996-07-25 Formulation
PCT/EP1997/003872 WO1998004258A1 (en) 1996-07-25 1997-07-14 Formulation for the treatment and/or prophylaxis of dementia

Publications (2)

Publication Number Publication Date
DE69715878D1 DE69715878D1 (de) 2002-10-31
DE69715878T2 true DE69715878T2 (de) 2003-05-22

Family

ID=10797487

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715878T Expired - Fee Related DE69715878T2 (de) 1996-07-25 1997-07-14 Formulierung zur behandlung und/oder vorbeugung von dementia

Country Status (24)

Country Link
EP (1) EP0918521B1 (de)
JP (1) JP2000515868A (de)
KR (1) KR20000029523A (de)
CN (1) CN1226163A (de)
AR (1) AR007983A1 (de)
AT (1) ATE224711T1 (de)
BR (1) BR9710546A (de)
CA (1) CA2261233A1 (de)
CO (1) CO5031290A1 (de)
CZ (1) CZ22799A3 (de)
DE (1) DE69715878T2 (de)
DK (1) DK0918521T3 (de)
ES (1) ES2184121T3 (de)
GB (1) GB9615628D0 (de)
HK (1) HK1021314A1 (de)
IL (1) IL128095A (de)
NO (1) NO990283L (de)
NZ (1) NZ333704A (de)
PL (1) PL331283A1 (de)
PT (1) PT918521E (de)
TR (1) TR199900141T2 (de)
TW (1) TW426514B (de)
WO (1) WO1998004258A1 (de)
ZA (1) ZA976592B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815383D0 (en) * 1998-07-15 1998-09-16 Smithkline Beecham Plc Novel method of treatment
MY127097A (en) * 2000-09-27 2006-11-30 Dsm Ip Assets Bv Process for the carbonylation of a conjugated diene
GB0428170D0 (en) * 2004-12-23 2005-01-26 Biopartners Ltd Mono and Combination Therapy
JP7293560B2 (ja) 2017-12-29 2023-06-20 グアンジョウ マキシノベル ファーマシューティカルズ カンパニー リミテッド 芳香族ビニルまたは芳香族エチル系誘導体、その製造方法、中間体、薬物組成物および使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69034146T2 (de) * 1989-04-13 2005-07-14 Beecham Group P.L.C., Brentford Chemische Verbindungen
MX9300875A (es) * 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
DE19501022C1 (de) * 1995-01-14 1996-06-05 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
PT918521E (pt) 2003-02-28
AR007983A1 (es) 1999-11-24
DK0918521T3 (da) 2003-02-03
WO1998004258A1 (en) 1998-02-05
NO990283L (no) 1999-03-19
CN1226163A (zh) 1999-08-18
AU3768497A (en) 1998-02-20
ATE224711T1 (de) 2002-10-15
GB9615628D0 (en) 1996-09-04
EP0918521B1 (de) 2002-09-25
ES2184121T3 (es) 2003-04-01
NZ333704A (en) 2000-06-23
EP0918521A1 (de) 1999-06-02
IL128095A (en) 2002-07-25
JP2000515868A (ja) 2000-11-28
PL331283A1 (en) 1999-07-05
CZ22799A3 (cs) 1999-06-16
DE69715878D1 (de) 2002-10-31
BR9710546A (pt) 1999-08-17
TR199900141T2 (xx) 1999-03-22
NO990283D0 (no) 1999-01-22
ZA976592B (en) 1999-03-04
CA2261233A1 (en) 1998-02-05
IL128095A0 (en) 1999-11-30
KR20000029523A (ko) 2000-05-25
CO5031290A1 (es) 2001-04-27
AU721101B2 (en) 2000-06-22
HK1021314A1 (en) 2000-06-09
TW426514B (en) 2001-03-21

Similar Documents

Publication Publication Date Title
DE69733329D1 (de) Verwendung von Taurin zur Behandlung oder Vorbeugung von ischämischen Verletzungen
DE69806579T2 (de) Anlage zur behandlung von nahrungsmitteln
ATE201138T1 (de) Verwendung von anti-mikrotubuli mitteln zur behandlung und prophylaxe der multiplen sclerose
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
ATE275383T1 (de) Oxadisäuren und verwandte verbindungen zur behandlung von hautstörungen
DE69942680D1 (de) Verfahren und Zusammensetzungen zur Prävention und Behandlung von Anämie
DE69832838D1 (de) Vorrichtung zur Aufbewahrung und/oder Behandlung von Chemikalien
DE69222258D1 (de) Einrichtung und Verfahren für die Behandlung von Aussenwänden
DE69115921D1 (de) Verfahren zur behandlung und verwendung von abfallstoffen
ATA11989A (de) Mittel zur vorbeugung gegen und behandlung von parodontopathien
DE60134009D1 (de) Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose
DE69812784D1 (de) Zusammensetzung zur Vorbeugung und Beseitigung von Pflanzenkrankheiten
DE69532066D1 (de) Arzneimittel zur Behandlung von Restenosis und Gefässsklerose
DE69825319D1 (de) Präparat zur vorbeugung und behandlung von entzündungen
DE69429101T2 (de) Verbindungen und zusammensetzungen zur behandlung von allergien und entzündungen
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE29718503U1 (de) Gerät zur Behandlung von Tinitus und Hyperakusis
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE69306335D1 (de) Prevention und Behandlung von Atherosclerosis
DE69222065T2 (de) Dapsone und promin zur behandlung der demenz
DE69715878D1 (de) Formulierung zur behandlung und/oder vorbeugung von dementia
DE3586420T2 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
ATE276752T1 (de) Verwendung von niedermolekularen heparinen zur vorbeugung und behandlung von einem trauma des zentralnervensystems

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee